Abstract
Proper supporting therapy for malignant patients is important for pain relief, safety of treatment, and improvement of treatment efficacy. This chapter focuses on the following three areas of supporting therapy.
-
1.
Tumor lysis syndrome.
-
2.
Chemotherapy-induced nausea and vomiting.
-
3.
Cancer pain management.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Cairo MS, Coiffier B, Reiter A, Younes A, Expert Panel TLS. Recommendations for the evaluation of risk and prophylaxis of tumour lysis syndrome (TLS) in adults and children with malignant diseases: an expert TLS panel consensus. Br J Med. 2010;149:578–86.
Hesketh PJ, Kris MG, Grungerg SM, Hainsworth JD, Harker G, Aapro MS, Gandara D, Lindley CM. Proposal for classifying the acute emetogenicity of cancer chemotherapy. J Clin Oncol. 1997;15:103–9.
WHO guidelines on the pharmacological treatment of persisting pain in children with medical illness. 2012. http://apps.who.int/medicinedocs/documents/s19116en/s19116en.pdf.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Yano, M. (2020). Supportive Therapy. In: Kato, M. (eds) Pediatric Acute Lymphoblastic Leukemia. Springer, Singapore. https://doi.org/10.1007/978-981-15-0548-5_16
Download citation
DOI: https://doi.org/10.1007/978-981-15-0548-5_16
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-15-0547-8
Online ISBN: 978-981-15-0548-5
eBook Packages: MedicineMedicine (R0)